Insider · CIK 0001650322
Jayson Donald Alexander Dallas
Files at DMRA (Damora Therapeutics, Inc.). First filing -, latest -.
Jayson Donald Alexander Dallas files SEC Form 4 as director at DMRA (Damora Therapeutics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Jayson Donald Alexander Dallas has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 18, 2025 | DMRA Damora Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +720 | $0.00 | $0 | 720 | Jun 20, 2025 |
Questions about Jayson Donald Alexander Dallas
Answered from the filings on this page, as of the latest one.
Is Jayson Donald Alexander Dallas buying or selling?
Jayson Donald Alexander Dallas has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Jayson Donald Alexander Dallas's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Jayson Donald Alexander Dallas has 0.
Where does Jayson Donald Alexander Dallas file Form 4?
Jayson Donald Alexander Dallas has filed Form 4 at DMRA (Damora Therapeutics, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.